Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - therapeuticarea
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
HLA-class II-restricted T Cell Receptors for PIK3CA “Hotspot” Mutations, E545K and N345K
Summary: The National Cancer Institute (NCI) seeks co-development partners and/or licensees for a collection of T cell receptors (TCRs) that specifically target PIK3CA mutations to treat patients with tumors expressing these mutations in the context of HLA-DPA1*01:03:01, HLA-DPB1*04:01:01 or HLA-DRB1*04:01. Description of Technology: Phosphatidylinositol-4,5-biphosphate...
Published: 11/10/2024
|
Inventor(s):
Steven Rosenberg
,
NIkolaos Zacharakis
,
S M Rafiqul Islam
,
Samantha Seitter
,
Maria Parkhurst
,
Frank Lowery
Keywords(s):
Category(s):
TherapeuticArea
,
TherapeuticArea
> Oncology
,
TherapeuticArea
> Immunology
,
Collaboration Sought > Collaboration
,
Application > Therapeutics
Pigment Epithelium-Derived Factor Peptides and Use for Treating Retinal Degeneration
Summary: The National Eye Institute (NEI) seeks research co-development partners and/or licensees for the development of an eyedrop formulation and/or AVV2-based delivery system to deliver the 17-mer [H105A] peptide to treat retinal degeneration. Description of Technology: Retinitis pigmentosa (RP) is one of the most common inherited retinal...
Published: 4/8/2024
|
Inventor(s):
S. Patricia Becerra
Keywords(s):
Category(s):
Application
,
TherapeuticArea
,
TherapeuticArea
> Eye / Ear / Nose / Throat
,
Collaboration Sought > Collaboration
T Cell Receptors Targeting the KRAS G13D Mutation in the Context of HLA-A11:01 for Research Use
Summary: The National Cancer Institute (NCI) has identified HLA-A11:01-restricted T Cell Receptors (TCRs) targeting the KRAS G13D mutation. The NCI seeks licensees for the use of these TCRs in research. Description of Technology: Tumor-specific mutated proteins can create immunogenic, mutation-containing “neoepitopes” which are attractive...
Published: 4/8/2024
|
Inventor(s):
Catherine Ade
,
Zhiya Yu
,
Matthew Sporn
,
James Yang
,
Kenichi Hanada
Keywords(s):
Category(s):
TherapeuticArea
,
Application
,
Application > Research Materials
,
Collaboration Sought > Licensing